Gene: NRXN3
Official Full Name: neurexin 3provided by HGNC
Gene Summary: This gene encodes a member of a family of proteins that function in the nervous system as receptors and cell adhesion molecules. Extensive alternative splicing and the use of alternative promoters results in multiple transcript variants and protein isoforms for this gene, but the full-length nature of many of these variants has not been determined. Transcripts that initiate from an upstream promoter encode alpha isoforms, which contain epidermal growth factor-like (EGF-like) sequences and laminin G domains. Transcripts initiating from the downstream promoter encode beta isoforms, which lack EGF-like sequences. Genetic variation at this locus has been associated with a range of behavioral phenotypes, including alcohol dependence and autism spectrum disorder. [provided by RefSeq, Dec 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO05404 | NRXN3 Knockout cell line (HEK293) | Human | NRXN3 | 1:3~1:6 | Negative | Online Inquiry |
NRXN3 Gene Knockout Cell Lines represent a cutting-edge tool in molecular biology, specifically designed to facilitate the study of the Neurexin-3 gene, one of the critical players in synaptic function and neural connectivity. These engineered cell lines have been created using CRISPR/Cas9 technology to disrupt the NRXN3 gene, enabling researchers to explore its role in various biological processes and diseases effectively.
The primary function of the NRXN3 knockout cell lines is to allow for the examination of neuronal development and synaptic transmission under conditions where the Neurexin-3 protein is absent. This provides insights into its implications in neurodevelopmental disorders, such as autism spectrum disorders and schizophrenia, where altered synaptic connectivity is often observed. By analyzing the differential expression of other synaptic proteins and assessing changes in synaptic activity, researchers can infer the mechanistic pathways influenced by NRXN3.
From a scientific standpoint, these cell lines hold immense value in both research and clinical settings. They are essential for performing genetic and pharmacological experiments, thereby contributing to the understanding of neurobiological processes and potential therapeutic interventions. The application of NRXN3 knockout models in functional assays allows for the development of targeted drug therapies, especially given the impact of Neurexin-3 on synaptic modulation and plasticity.
What sets our NRXN3 Gene Knockout Cell Lines apart from alternatives is their high specificity and reliability, achieved through rigorous validation processes to confirm complete knockout of the target gene. Unlike competing products, our lines are optimized for consistency in experimental outcomes, ensuring reproducibility crucial for advanced research applications.
For researchers and clinicians focused on neurobiology and related fields, utilizing NRXN3 knockout cell lines enhances the ability to decipher the complexities of synaptic communication and its implications in mental health disorders. Our company prides itself on a commitment to high-quality, innovative biological products, leveraging extensive expertise in genetic engineering and cell line development to support researchers in advancing their scientific discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.